Bristol-Myers Squibb Co (FRA:BRM) Accumulated other comprehensive income (loss) : €-1,288 Mil (As of Mar. 2024)

View and export this data going back to 1952. Start your Free Trial

What is Bristol-Myers Squibb Co Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Bristol-Myers Squibb Co's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-1,288 Mil.

Bristol-Myers Squibb Co's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (€-1,205 Mil) to Dec. 2023 (€-1,418 Mil) but then increased from Dec. 2023 (€-1,418 Mil) to Mar. 2024 (€-1,288 Mil).

Bristol-Myers Squibb Co's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-1,122 Mil) to Dec. 2022 (€-1,209 Mil) and declined from Dec. 2022 (€-1,209 Mil) to Dec. 2023 (€-1,418 Mil).

Bristol-Myers Squibb Co Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Bristol-Myers Squibb Co's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Accumulated other comprehensive income (loss) Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-1,368.00

-1,511.66

-1,122.18

-1,209.26

-1,417.68

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-1,277.71	-1,280.20	-1,204.98	-1,417.68	-1,288.00

Bristol-Myers Squibb Co Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Bristol-Myers Squibb Co Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (FRA:BRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (FRA:BRM) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (FRA:BRM) Headlines

No Headlines